Brain Delivery of Curcumin Through Low-Intensity Ultrasound-Induced Blood–Brain Barrier Opening via Lipid-PLGA Nanobubbles

BACKGROUND: Parkinson’s disease (PD) is a progressive neurodegenerative disorder. Owing to the presence of blood–brain barrier (BBB), conventional pharmaceutical agents are difficult to the diseased nuclei and exert their action to inhibit or delay the progress of PD. Recent literatures have demonst...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Yiran, Chen, Yan, Liu, Zhongxun, Cai, Feiyan, Niu, Wanting, Song, Liming, Liang, Haifeng, Su, Zhiwen, Yu, Bo, Yan, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575349/
https://www.ncbi.nlm.nih.gov/pubmed/34764649
http://dx.doi.org/10.2147/IJN.S327737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575349/
https://www.ncbi.nlm.nih.gov/pubmed/34764649
http://dx.doi.org/10.2147/IJN.S327737

Ejemplares similares